how to micro dose semaglutide Microdose Microdose GLP-1 for Women -

The FDA approved oral semaglutide 25 mg (Wegovy tablet) on December 22, 2025, based on the phase 3 OASIS 4 clinical trial

If the medication genuinely does not appear to be effective for you after a reasonable trial period with appropriate lifestyle support, your clinician can discuss alternatives

doi: 10.1002/osp4.22

As tolerance improves, patients can gradually reintroduce higher-fiber foods and expand dietary variety while monitoring symptoms

However, GLP-1 receptors exist on immune cells, so theoretical autoimmune modulation is possible

This episode is raw, conversational, and experience-driven exactly how these Q&As are meant to be